---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-071716"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:46:00.979948+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA shareholders approve asset sale to Gilead and company dissolution

## Summary
- Asset sale to Gilead Sciences approved: 5,063,462 for, 239,595 against, 1,502 abstain.
- Plan of liquidation and dissolution approved: 4,969,875 for, 329,803 against, 4,881 abstain.
- Adjournment proposal approved: 5,110,153 for, 191,383 against, 3,023 abstain.
- Special meeting held July 29, 2025; 54.13% of outstanding shares voted.
- Company will proceed with dissolution following asset sale closing.

## SEC filing metadata
- accession: 0001104659-25-071716
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/0001104659-25-071716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/tm2521991d7_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-071716
- JSON: https://secwatch.observer/filing/0001104659-25-071716.json
- Plain text: https://secwatch.observer/filing/0001104659-25-071716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.